Alerts will be sent to your verified email
Verify EmailESCONET
Esconet Technologies
|
Balaxi Pharma.
|
Emerald Leisures
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
32.8 % | 29.33 % | 15.5 % |
5yr average Equity Multiplier
|
5.77 | 1.4 | -0.81 |
5yr Average Asset Turnover Ratio
|
2.65 | 1.5 | 0.11 |
5yr Avg Net Profit Margin
|
2.71 % | 11.83 % | -54.81 % |
Price to Book
|
0.0 | 1.24 | 0.0 |
P/E
|
35.91 | 11.44 | 0.0 |
5yr Avg Cash Conversion Cycle
|
30.8 Days | 133.11 Days | -267.65 Days |
Inventory Days
|
31.3 Days | 68.7 Days | 528.23 Days |
Days Receivable
|
64.8 Days | 81.67 Days | 0.0 |
Days Payable
|
62.98 Days | 60.92 Days | 4139.92 Days |
5yr Average Interest Coverage Ratio
|
3.94 | 92.41 | -0.36 |
5yr Avg ROCE
|
36.01 % | 40.34 % | -42.06 % |
5yr Avg Operating Profit Margin
|
5.46 % | 18.05 % | 20.07 % |
5 yr average Debt to Equity
|
1.72 | 0.05 | -1.45 |
5yr CAGR Net Profit
|
49.79 % | n/a | -1.83 % |
5yr Average Return on Assets
|
6.98 % | 20.09 % | -23.13 % |
Shareholdings
|
|||
Promoter Holding
|
61.3 % | 65.99 % | 73.76 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 24.01 % |
Change in Promoter Holding (3 Yrs)
|
-3.64 % | -6.87 % | 4.69 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Esconet Technologies
|
Balaxi Pharma.
|
Emerald Leisures
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Customer Wise Break-Up
|
Customer Wise Break-Up
|
-
|
-
|